Jefferies Financial Group Inc. Buys 172,310 Shares of Corteva, Inc. $CTVA

Jefferies Financial Group Inc. bought a new stake in shares of Corteva, Inc. (NYSE:CTVA) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 172,310 shares of the company’s stock, valued at approximately $13,380,000.

Other hedge funds have also recently bought and sold shares of the company. EFG International AG acquired a new position in shares of Corteva in the 2nd quarter valued at approximately $25,000. Compass Financial Management LLC purchased a new position in shares of Corteva during the 2nd quarter valued at approximately $25,000. Elevation Wealth Partners LLC boosted its stake in shares of Corteva by 334.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after buying an additional 261 shares during the last quarter. Clearstead Trust LLC acquired a new stake in shares of Corteva during the second quarter worth approximately $31,000. Finally, N.E.W. Advisory Services LLC acquired a new stake in shares of Corteva during the second quarter worth approximately $33,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on CTVA shares. KeyCorp upgraded shares of Corteva from a “sector weight” rating to an “overweight” rating and set a $17.00 price target for the company in a research note on Wednesday, October 7th. Citigroup increased their price objective on shares of Corteva from $86.00 to $91.00 and gave the company a “neutral” rating in a research note on Thursday, September 17th. Oppenheimer set a $17.00 price objective on shares of Corteva in a research note on Monday, October 5th. Weiss Ratings lowered shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Finally, Morgan Stanley reissued an “overweight” rating and issued a $18.00 target price on shares of Corteva in a research report on Friday, October 2nd. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $60.59.

Corteva Trading Up 0.2%

Shares of NYSE CTVA opened at $12.20 on Thursday. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The stock’s 50 day moving average price is $40.43 and its two-hundred day moving average price is $70.20. Corteva, Inc. has a 52-week low of $11.24 and a 52-week high of $90.97. The stock has a market capitalization of $8.14 billion, a P/E ratio of 8.08, a PEG ratio of 1.70 and a beta of 0.58.

Corteva (NYSE:CTVA) last issued its earnings results on Wednesday, November 11th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.02 by $0.04. Corteva had a return on equity of 10.18% and a net margin of 5.66%. The company had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same quarter last year, the firm earned ($0.23) EPS. The business’s revenue was down 8.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 0.760-0.800 EPS. On average, analysts anticipate that Corteva, Inc. will post 1.05 earnings per share for the current fiscal year.

Corteva Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Tuesday, December 1st will be given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date is Tuesday, December 1st. This is a decrease from Corteva’s previous quarterly dividend of $0.18. Corteva’s payout ratio is 47.68%.

Corteva Company Profile

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.